Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study | The Journal of Headache and Pain | Full Text

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study | The Journal of Headache and Pain | Full Text

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study

The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were asses...

Authors:Dawn C. Buse, Sanjay K. Gandhi, Joshua M. Cohen, Verena Ramirez-Campos, Blaine Cloud, Ronghua Yang and Robert P. Cowan

Citation:The Journal of Headache and Pain 2020 21:109

Content type:Research article

 

Published on: 4 September 2020

• ViewFull Text
 
• ViewPDF